The Latin America, Middle East and Africa Virtual Clinical Trials Market would witness market growth of 7.4% CAGR during the forecast period (2020-2026). Growing demand for the latest medical tools and medicines among end-users, combined with rising investment for R&D initiatives for the growth of effective medicines are significant components boosting the growth of the worldwide clinical trials market during the forecast period. Moreover, the growing number of people who suffer from chronic diseases and changing circumstances and nature of specific kinds of chronic diseases is another component expected to boost the growth of the virtual clinical trials market to a large extent.
The growing requirement to create new therapeutics for chronic disorders like cancer, respiratory diseases, diabetes, cardiovascular disease, and others is putting massive pressure on healthcare. The global outbreak of the COVID-19 and the rising demand for creating an appropriate treatment for the same is boosting the growth of the market.
Monitoring of remote patients and virtual visits to physical site visits provide members a choice and comfort of not prone to unnecessary dangers. The virtual examination empowers sponsors to include a bigger population in the research, hence enhancing recruitment, engagement, and retention. Besides, it allows continuous and real-time collection of data with the help of digital health technologies. Finally, virtual connectivity, management, and monitoring can majorly reduce the effort, participants’ burden and time commitments, CRCs, and investigators.
Based on Study Type, the market is segmented into Interventional, Observational, and Expanded Access and Others. Based on Indication, the market is segmented into Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and Other Indications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Virtual Clinical Trials Market in LAMEA is expected to register a CAGR of 7.4% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., ICON PLC, Laboratory Corporation of America Holdings (Covance, Inc.), Dassault Systemes SE (Medidata Solutions, Inc.), Oracle Corporation, Parexel International Corporation (Pamplona Capital Management), PRA Health Sciences, Inc. (KKR & Co., Inc.), Medpace Holdings, Inc., Medable, Inc. and Clinical Ink, Inc. (G.I. Partners)
Scope of the Study
Market Segments Covered in the Report:
By Study Type
- Interventional
- Observational
- Expanded Access
- Others
By Indication
- Oncology
- Cardiovascular
- Immunology
- Gastrointestinal
- Respiratory
- Endocrinology
- Ophthalmology
- Other Indications
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- IQVIA Holdings, Inc.
- ICON PLC
- Laboratory Corporation of America Holdings (Covance, Inc.)
- Dassault Systemes SE (Medidata Solutions, Inc.)
- Oracle Corporation
- Parexel International Corporation (Pamplona Capital Management)
- PRA Health Sciences, Inc. (KKR & Co., Inc.)
- Medpace Holdings, Inc.
- Medable, Inc.
- Clinical Ink, Inc. (G.I. Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Virtual Clinical Trials Market, by Study Type
1.4.2 LAMEA Virtual Clinical Trials Market, by Indication
1.4.3 LAMEA Virtual Clinical Trials Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Nov) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
Chapter 4. LAMEA Virtual Clinical Trials Market by Study Type
4.1 LAMEA Interventional Market by Country
4.2 LAMEA Observational Market by Country
4.3 LAMEA Expanded Access Market by Country
Chapter 5. LAMEA Virtual Clinical Trials Market by Indication
5.1 LAMEA Oncology Market by Country
5.2 LAMEA Cardiovascular Market by Country
5.3 LAMEA Immunology Market by Country
5.4 LAMEA Gastrointestinal Market by Country
5.5 LAMEA Respiratory Market by Country
5.6 LAMEA Endocrinology Market by Country
5.7 LAMEA Ophthalmology Market by Country
5.8 LAMEA Other Indications Market by Country
Chapter 6. LAMEA Virtual Clinical Trials Market by Country
6.1 Brazil Virtual Clinical Trials Market
6.1.1 Brazil Virtual Clinical Trials Market by Study Type
6.1.2 Brazil Virtual Clinical Trials Market by Indication
6.2 Argentina Virtual Clinical Trials Market
6.2.1 Argentina Virtual Clinical Trials Market by Study Type
6.2.2 Argentina Virtual Clinical Trials Market by Indication
6.3 UAE Virtual Clinical Trials Market
6.3.1 UAE Virtual Clinical Trials Market by Study Type
6.3.2 UAE Virtual Clinical Trials Market by Indication
6.4 Saudi Arabia Virtual Clinical Trials Market
6.4.1 Saudi Arabia Virtual Clinical Trials Market by Study Type
6.4.2 Saudi Arabia Virtual Clinical Trials Market by Indication
6.5 South Africa Virtual Clinical Trials Market
6.5.1 South Africa Virtual Clinical Trials Market by Study Type
6.5.2 South Africa Virtual Clinical Trials Market by Indication
6.6 Nigeria Virtual Clinical Trials Market
6.6.1 Nigeria Virtual Clinical Trials Market by Study Type
6.6.2 Nigeria Virtual Clinical Trials Market by Indication
6.7 Rest of LAMEA Virtual Clinical Trials Market
6.7.1 Rest of LAMEA Virtual Clinical Trials Market by Study Type
6.7.2 Rest of LAMEA Virtual Clinical Trials Market by Indication
Chapter 7. Company Profiles
7.1 IQVIA Holdings, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 ICON PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.1 Recent strategies and developments:
7.2.1.1 Partnerships, Collaborations, and Agreements:
7.2.1.2 Product Launches and Product Expansions:
7.2.1.3 Acquisition and Mergers:
7.3 Laboratory Corporation of America Holdings (Covance, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Product Launches and Product Expansions:
7.3.4.2 Acquisition and Mergers:
7.4 Dassault Systemes SE (Medidata Solutions, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Oracle Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.6 Parexel International Corporation (Pamplona Capital Management)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Product Launches and Product Expansions:
7.6.2.3 Geographical Expansions:
7.7 PRA Health Sciences, Inc. (KKR & Co., Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Partnerships, Collaborations, and Agreements:
7.7.4.2 Product Launches and Product Expansions:
7.8 Medpace Holdings, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Recent strategies and developments:
7.8.3.1 Partnerships, Collaborations, and Agreements:
7.9 Medable, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Product Launches and Product Expansions:
7.10. Clinical Ink, Inc. (G.I. Partners)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 LAMEA Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 2 LAMEA Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Virtual Clinical Trials Market
TABLE 4 Product Launches And Product Expansions– Virtual Clinical Trials Market
TABLE 5 Geographical Expansions – Virtual Clinical Trials Market
TABLE 6 Acquisition and Mergers– Virtual Clinical Trials Market
TABLE 7 LAMEA Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 8 LAMEA Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 9 LAMEA Interventional Market by Country, 2016 - 2019, USD Million
TABLE 10 LAMEA Interventional Market by Country, 2020 - 2026, USD Million
TABLE 11 LAMEA Observational Market by Country, 2016 - 2019, USD Million
TABLE 12 LAMEA Observational Market by Country, 2020 - 2026, USD Million
TABLE 13 LAMEA Expanded Access Market by Country, 2016 - 2019, USD Million
TABLE 14 LAMEA Expanded Access Market by Country, 2020 - 2026, USD Million
TABLE 15 LAMEA Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 16 LAMEA Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 17 LAMEA Oncology Market by Country, 2016 - 2019, USD Million
TABLE 18 LAMEA Oncology Market by Country, 2020 - 2026, USD Million
TABLE 19 LAMEA Cardiovascular Market by Country, 2016 - 2019, USD Million
TABLE 20 LAMEA Cardiovascular Market by Country, 2020 - 2026, USD Million
TABLE 21 LAMEA Immunology Market by Country, 2016 - 2019, USD Million
TABLE 22 LAMEA Immunology Market by Country, 2020 - 2026, USD Million
TABLE 23 LAMEA Gastrointestinal Market by Country, 2016 - 2019, USD Million
TABLE 24 LAMEA Gastrointestinal Market by Country, 2020 - 2026, USD Million
TABLE 25 LAMEA Respiratory Market by Country, 2016 - 2019, USD Million
TABLE 26 LAMEA Respiratory Market by Country, 2020 - 2026, USD Million
TABLE 27 LAMEA Endocrinology Market by Country, 2016 - 2019, USD Million
TABLE 28 LAMEA Endocrinology Market by Country, 2020 - 2026, USD Million
TABLE 29 LAMEA Ophthalmology Market by Country, 2016 - 2019, USD Million
TABLE 30 LAMEA Ophthalmology Market by Country, 2020 - 2026, USD Million
TABLE 31 LAMEA Other Indications Market by Country, 2016 - 2019, USD Million
TABLE 32 LAMEA Other Indications Market by Country, 2020 - 2026, USD Million
TABLE 33 LAMEA Virtual Clinical Trials Market by Country, 2016 - 2019, USD Million
TABLE 34 LAMEA Virtual Clinical Trials Market by Country, 2020 - 2026, USD Million
TABLE 35 Brazil Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 36 Brazil Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 37 Brazil Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 38 Brazil Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 39 Brazil Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 40 Brazil Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 41 Argentina Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 42 Argentina Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 43 Argentina Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 44 Argentina Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 45 Argentina Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 46 Argentina Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 47 UAE Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 48 UAE Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 49 UAE Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 50 UAE Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 51 UAE Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 52 UAE Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 53 Saudi Arabia Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 54 Saudi Arabia Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 55 Saudi Arabia Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 56 Saudi Arabia Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 57 Saudi Arabia Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 58 Saudi Arabia Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 59 South Africa Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 60 South Africa Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 61 South Africa Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 62 South Africa Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 63 South Africa Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 64 South Africa Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 65 Nigeria Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 66 Nigeria Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 67 Nigeria Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 68 Nigeria Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 69 Nigeria Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 70 Nigeria Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 71 Rest of LAMEA Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 72 Rest of LAMEA Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 73 Rest of LAMEA Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 74 Rest of LAMEA Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 75 Rest of LAMEA Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 76 Rest of LAMEA Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 77 Key information – IQVIA Holdings, Inc.
TABLE 78 Key Information – ICON PLC
TABLE 79 Key Information – Laboratory Corporation of America holdings
TABLE 80 Key Information – Dassault Systemes SE
TABLE 81 Key Information – Oracle Corporation
TABLE 82 Key Information – PAREXEL International Corporation
TABLE 83 Key Information – PRA Health Sciences, Inc.
TABLE 84 key Information – Medpace Holdings, Inc.
TABLE 85 Key Information – Medable, Inc.
TABLE 86 Key Information – Clinical Ink, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Feb – 2020, Dec) Leading Players
FIG 5 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
FIG 6 Recent strategies and developments: IQVIA Holdings, Inc.
FIG 7 Recent strategies and developments: ICON PLC
FIG 8 Recent strategies and developments: Laboratory Corporation of America
FIG 9 Recent strategies and developments: Dassault Systemes SE
FIG 10 Recent strategies and developments: Oracle Corporation
FIG 11 Recent strategies and developments: Parexel International Corporation
FIG 12 Recent strategies and developments: PRA Health Sciences, Inc.
FIG 13 Recent strategies and developments: Medable, Inc.